Literature DB >> 26434596

Histopathological features of sinonasal inverted papillomas in chinese patients.

Li Zhao1,2, Chun Wei Li3, Peng Jin1,2, Chew Lip Ng3, Zhi Bin Lin4, Ying Ying Li3, Tian Ying Li4, Bengt Fredrik Petersson5, Li Shi1,2, De Yun Wang3.   

Abstract

OBJECTIVES/HYPOTHESIS: Nasal inverted papilloma (IP) is a benign tumor with high recurrence rates. Evidence of inflammation has been reported in IP in Caucasian studies. This study aimed to investigate the histopathological patterns and their associations with clinical characteristics in Chinese patients with IP. STUDY
DESIGN: Basic science study.
METHODS: IP tissues were obtained from 50 Chinese patients with unilateral IPs. Biopsies of inferior turbinate mucosa from 17 healthy subjects were used as controls. The histological patterns and severity of epithelial remodeling and inflammatory cell infiltration were evaluated and analyzed for associations with clinical characteristics.
RESULTS: Thirty-one percent of IP specimens were classified as grade I (mild remodeling) and 49% as grade II (moderate and severe remodeling). Concomitant inflammatory nasal polyps were found in 14 patients (28%). Recurrent IP was strongly associated with grade II (odds ratio: 5.81, 95% confidence interval: 1.34-25.18). Except CD4(+) T cells, quantities of neutrophils, macrophages, eosinophils, CD8(+) T cells, and FoxP3(+) T-reg cells were significantly elevated in IP. Of these, neutrophils were the predominant cell type in IP.
CONCLUSIONS: Inflammation may have potential roles in IPs and the higher grade of epithelial remodeling was associated with the recurrence of IPs. LEVEL OF EVIDENCE: NA.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Chinese; Inverted papilloma; epithelial metaplasia; inflammation; recurrence

Mesh:

Year:  2015        PMID: 26434596     DOI: 10.1002/lary.25694

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Prevalence and association of Epstein-Barr virus infection with sinonasal inverted papilloma and sinonasal squamous cell carcinoma in the northeastern Thai population.

Authors:  Thawaree Nukpook; Tipaya Ekalaksananan; Watchareporn Teeramatwanich; Natcha Patarapadungkit; Surachat Chaiwiriyakul; Patravoot Vatanasapt; Sirinart Aromseree; Chamsai Pientong
Journal:  Infect Agent Cancer       Date:  2020-06-24       Impact factor: 2.965

2.  Abnormal Expression of YAP Is Associated With Proliferation, Differentiation, Neutrophil Infiltration, and Adverse Outcome in Patients With Nasal Inverted Papilloma.

Authors:  Tian Yuan; Rui Zheng; Xiang-Min Zhou; Peng Jin; Zhi-Qun Huang; Xiao-Xue Zi; Qing-Wu Wu; Wei-Hao Wang; Hui-Yi Deng; Wei-Feng Kong; Hui-Jun Qiu; Sui-Zi Zhou; Qian-Min Chen; Yan-Yi Tu; Tao Li; Jing Liu; Kai Sen Tan; Hsiao Hui Ong; Li Shi; Zhuang-Gui Chen; Xue-Kun Huang; Qin-Tai Yang; De-Yun Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-15

3.  Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network.

Authors:  Min Lu; Jiaqi Li; Xin Fan; Fei Xie; Jie Fan; Yuanping Xiong
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

4.  Dynamic Incision under Nasal Endoscope and Low-Temperature Plasma Radiofrequency Ablation for Nasal Inverted Papilloma: An Analysis of Differences in Efficacy and the Destructive Effect on Immune Function.

Authors:  Fang Liu; Fei Ye; Xilan Gu; Wenbin Wang; Xiaodong Yin
Journal:  Comput Math Methods Med       Date:  2022-10-09       Impact factor: 2.809

Review 5.  Etiology of sinonasal inverted papilloma: A narrative review.

Authors:  Ming-Jie Wang; Julia E Noel
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-12-21

6.  Overexpression of Neutrophil MMP-9 and HIF-1α May Contribute to the Finger-Like Projections Formation and Histo-Pathogenesis in Nasal Inverted Papilloma.

Authors:  Tao Li; Kai Sen Tan; Yan Yi Tu; Li Zhao; Jing Liu; Hsiao Hui Ong; De Yun Wang; Li Shi
Journal:  J Inflamm Res       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.